Financial Performance Highlights (in ₹ Lakhs)

Quarter Ended June 30, 2026 (Unaudited):

  • Revenue from Operations: ₹6,648.68 lakhs (₹66.49 crore)
  • Other Income: ₹372.38 lakhs
  • Total Income: ₹7,021.06 lakhs
  • Total Expenses: ₹5,565.88 lakhs
  • Profit Before Tax: ₹1,455.18 lakhs
  • Tax Expense: ₹358.89 lakhs (Current Tax: ₹352.32 lakhs, Deferred Tax: ₹6.57 lakhs)
  • Net Profit for the Period: ₹1,096.29 lakhs (₹10.96 crore)
  • Other Comprehensive Income: (₹0.65) lakhs
  • Total Comprehensive Income: ₹1,095.64 lakhs
  • Basic and Diluted EPS: ₹2.99 (face value ₹10 per share)
  • Equity Share Capital: ₹3,663.07 lakhs

Comparative Performance:

Quarter-over-Quarter Comparison (Q1 FY27 vs Q4 FY26):

  • Revenue decreased from ₹7,542.17 lakhs to ₹6,648.68 lakhs (-11.8%)
  • Net Profit increased from ₹637.13 lakhs to ₹1,096.29 lakhs (+72.1%)

Year-over-Year Comparison (Q1 FY27 vs Q1 FY26):

  • Revenue increased from ₹5,351.80 lakhs to ₹6,648.68 lakhs (+24.2%)
  • Net Profit increased from ₹638.71 lakhs to ₹1,096.29 lakhs (+71.6%)

Expense Breakdown (Q1 FY27):

  • Cost of Materials Consumed: ₹4,226.76 lakhs
  • Purchases of Stock-in-Trade: ₹222.91 lakhs
  • Changes in Inventories: (₹761.25) lakhs (decrease)
  • Employee Benefit Expenses: ₹570.30 lakhs
  • Finance Costs: ₹85.38 lakhs
  • Depreciation and Amortization: ₹374.98 lakhs
  • Other Expenses: ₹846.80 lakhs

Regulatory and Compliance Information

  • Financial results prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) "Interim Financial Reporting"
  • Review conducted by Shah Mehta & Bakshi Chartered Accountants under Standards on Review Engagement (SRE) 2410
  • Review provides moderate assurance that financial statements are free from material misstatement
  • Results reviewed by Audit Committee and approved by Board of Directors on August 3, 2026

Business Segment Information

  • The company operates in a single reportable segment: manufacturing of Specialty Chemicals
  • No subsidiary, associate, or joint venture companies as of June 30, 2026

Additional Notes

  • Corresponding previous year/period figures have been regrouped/rearranged for comparability
  • Figures for quarter ended March 31, 2026 are balancing figures between audited full-year and published year-to-date figures

Auditor's Conclusion

Based on their review, nothing has come to their attention that causes them to believe that the financial statements:

1. Are not presented in accordance with Regulation 33 requirements

2. Contain any material misstatement

3. Fail to disclose required information as per regulations

The statement is prepared in accordance with recognition and measurement principles of Ind AS specified under Section 133 of the Companies Act, 2013.